Allostery: The Good, the Bad, and the Ugly
The Journal of Pharmacology and Experimental Therapeutics · 2024-01 · 388 (1) · 110-120
DOI: 10.1124/jpet.123.001838 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Pharmacology and Experimental Therapeutics, 2024-01. Verfasst von Terry Kenakin. Beteiligte Einrichtung: Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina kenakin@email.unc.edu. Hauptthemen laut MEDLINE: Drug Discovery, Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 77 Literaturangaben.
Abstract (Originalsprache)
With the advent of functional screening, more allosteric molecules are being discovered and developed as possible therapeutic entities. Allosteric proteins are unique because of two specific properties: 1) separate binding sites for allosteric modulators and guests and 2) mandatory alteration of receptor conformation upon binding of allosteric modulators. For G protein-coupled receptors, these properties produce many beneficial effects on pharmacologic systems that are described here. Allosteric discovery campaigns also bring with them added considerations that must be addressed for the endeavor to be successful, and these are described herein as well. SIGNIFICANCE STATEMENT: Recent years have seen the increasing presence of allosteric molecules as possible therapeutic drug candidates. The scientific procedures to characterize these are unique and require special techniques, so it is imperative that scientists understand the new concepts involved in allosteric function. This review examines the reasons why allosteric molecules should be considered as new drug entities and the techniques required to optimize the discovery process for allosteric molecules.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina kenakin@email.unc.edu.
Zitieren
APA
Kenakin, T. (2024). Allostery: The Good, the Bad, and the Ugly. The Journal of Pharmacology and Experimental Therapeutics, 388(1), 110-120. https://doi.org/10.1124/jpet.123.001838
Vancouver
Kenakin T. Allostery: The Good, the Bad, and the Ugly. The Journal of Pharmacology and Experimental Therapeutics. 2024;388(1):110-120. doi:10.1124/jpet.123.001838
BibTeX
@article{Kenakin2024,
author = {Kenakin, Terry},
title = {Allostery: The Good, the Bad, and the Ugly},
journal = {The Journal of Pharmacology and Experimental Therapeutics},
year = {2024},
volume = {388},
number = {1},
pages = {110--120},
doi = {10.1124/jpet.123.001838}
}
EUVIMED